Seller comparison · US self-pay prices

Remedy Meds vs Noom: GLP-1 Prices Compared

Remedy Meds and Noom both sell compounded semaglutide injection. Compounded semaglutide injection: about $21 less per 30 days at Noom: ≈ $299 per 30 days, against ≈ $320 per 30 days at Remedy Meds. Only Remedy Meds sells compounded tirzepatide injection here. Both sell only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. Prices checked Oct 13, 2026 and Oct 17, 2026.

Compare all 3 offers Remedy Meds prices Noom prices

Every cash quote was checked on or after Oct 13, 2026. Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices

Same product

What Remedy Meds and Noom charge for the same medication

Entry prices first, then the published top-dose price where either seller states one. Each price links the seller's own page.

Compounded semaglutide injection

Entry price: about $21 less per 30 days at Noom: ≈ $299 per 30 days, against ≈ $320 per 30 days at Remedy Meds.

RMRemedy Meds

Advertised entry price

$299 per 4 weeks

28-day supply

≈ $320.36 per 30 days at this quoted rate

Checked Oct 17, 2026

Compounded semaglutide via Remedy Meds

Remedy Meds · Sourced provider quote

monthly plan, a 4-week supply with no commitment, after a $179 first month; prescription, physician care and 48-hour cold-chain delivery included; the price does not rise with your dose

Price conditions

monthly plan, a 4-week supply with no commitment, after a $179 first month; prescription, physician care and 48-hour cold-chain delivery included; the price does not rise with your dose

Weekly injection. A 3-month bundle (12-week supply) is $597 with a 3-month commitment. Remedy's terms allow its fees to change on 30 days' notice, while the product pages promise the price never rises. Cash pay only. Compounded; not FDA-approved.

28-day supply

View offer

NNoom

Advertised entry price

$279/28 days

28-day supply · 3-month upfront payment required

≈ $298.93 per 30 days at this quoted rate

Checked Oct 13, 2026

Compounded semaglutide via Noom Med

Noom · Sourced provider quote

after $129 for the first 4 weeks; billed $837 every 12 weeks; medication, clinician visits and coaching included

Price conditions

after $129 for the first 4 weeks; billed $837 every 12 weeks; medication, clinician visits and coaching included

The recurring price for new accounts rose from $249 to $279 in July 2026 (an older FAQ on the same page still shows $249). Microdose semaglutide: $79 for the first 4 weeks, then $179/mo. Compounded; not FDA-approved.

28-day supply · 3-month upfront payment required

View offer

Sold by one of them

What only one of them sells

RMRemedy Meds

Compounded tirzepatide injection
Advertised entry price
$399 per 4 weeks
28-day supply
≈ $427.50 per 30 days at this quoted rate
Checked Oct 17, 2026
Compounded tirzepatide via Remedy Meds
Remedy Meds · Sourced provider quote
monthly plan, a 4-week supply with no commitment, after a $279 first month; prescription, physician care and 48-hour cold-chain delivery included; the price does not rise with your dose
Price conditions
monthly plan, a 4-week supply with no commitment, after a $279 first month; prescription, physician care and 48-hour cold-chain delivery included; the price does not rise with your dose
Weekly injection. A 3-month bundle (12-week supply) is $897 with a 3-month commitment. Cash pay only. Compounded; not FDA-approved.
28-day supply
View offer

NNoom

Everything Noom sells here is also sold by the other seller (above).

Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss

Every sourced offer

All Remedy Meds and Noom offers

Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.

Search with AIA brand, a budget, or what you need

Try

3 offers · US self-pay

Compounded semaglutide via Noom Med
Semaglutide · Compounded
Compounded · Not FDA-approved
N
Noom
Advertised price$279/28 days
28-day supply · 3-month upfront payment required
≈ $298.93 per 30 days
Checked Oct 13, 2026
Maintenance price
No separate dose price verified
View offer
Price conditions & source
Advertised price: after $129 for the first 4 weeks; billed $837 every 12 weeks; medication, clinician visits and coaching included
The recurring price for new accounts rose from $249 to $279 in July 2026 (an older FAQ on the same page still shows $249). Microdose semaglutide: $79 for the first 4 weeks, then $179/mo. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source
Compounded semaglutide via Remedy Meds
Semaglutide · Compounded
Compounded · Not FDA-approved
RM
Remedy Meds
Advertised price$299 per 4 weeks
28-day supply
≈ $320.36 per 30 days
Checked Oct 17, 2026
Maintenance price
No separate dose price verified
View offer
Price conditions & source
Advertised price: monthly plan, a 4-week supply with no commitment, after a $179 first month; prescription, physician care and 48-hour cold-chain delivery included; the price does not rise with your dose
Weekly injection. A 3-month bundle (12-week supply) is $597 with a 3-month commitment. Remedy's terms allow its fees to change on 30 days' notice, while the product pages promise the price never rises. Cash pay only. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source
Compounded tirzepatide via Remedy Meds
Tirzepatide · Compounded
Compounded · Not FDA-approved
RM
Remedy Meds
Advertised price$399 per 4 weeks
28-day supply
≈ $427.50 per 30 days
Checked Oct 17, 2026
Maintenance price
No separate dose price verified
View offer
Price conditions & source
Advertised price: monthly plan, a 4-week supply with no commitment, after a $279 first month; prescription, physician care and 48-hour cold-chain delivery included; the price does not rise with your dose
Weekly injection. A 3-month bundle (12-week supply) is $897 with a 3-month commitment. Cash pay only. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source

Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.

Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.

The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of September 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.

Questions

Remedy Meds vs Noom: common questions

Is Remedy Meds or Noom cheaper for GLP-1 medication?

Compounded semaglutide injection: about $21 less per 30 days at Noom: ≈ $299 per 30 days, against ≈ $320 per 30 days at Remedy Meds. Only Remedy Meds: Compounded tirzepatide injection $399 per 4 weeks. Prices are the sellers' own advertised self-pay prices, with the conditions listed beside each.

Do Remedy Meds and Noom sell FDA-approved GLP-1s or compounded versions?

Both sell only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.

What do Remedy Meds and Noom prices include?

Remedy Meds, compounded semaglutide injection: $299 per 4 weeks, monthly plan, a 4-week supply with no commitment, after a $179 first month; prescription, physician care and 48-hour cold-chain delivery included; the price does not rise with your dose. Noom, compounded semaglutide injection: $279/28 days, after $129 for the first 4 weeks; billed $837 every 12 weeks; medication, clinician visits and coaching included. Remedy Meds, compounded tirzepatide injection: $399 per 4 weeks, monthly plan, a 4-week supply with no commitment, after a $279 first month; prescription, physician care and 48-hour cold-chain delivery included; the price does not rise with your dose.

When were Remedy Meds and Noom prices last checked?

Prices checked Oct 13, 2026 and Oct 17, 2026. Each quote links the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.